“Efficacy of Abrocitinib and Dupilumab in Patients With Moderate-to-Severe Atopic Dermatitis With Severe Itch at Baseline and in Subgroups by Baseline Thresholds of Severe Itch: A Post Hoc Analysis of the JADE COMPARE and JADE DARE Clinical Trials” (2024) SKIN The Journal of Cutaneous Medicine, 8(2), p. s380. doi:10.25251/skin.8.supp.380.